Heffter Research Institute is proud to have supported new psilocybin studies published December 1 in The Journal of Psychopharmacology reporting the effectiveness of using psilocybin to reduce depression, anxiety and existential distress in cancer patients. Below is a round-up of articles discussing the recent findings of the NYU School of Medicine and Johns Hopkins University studies.

 

 

Have questions about psilocybin research? Contact Heffter Research Institute for more information.